SCHEMBL2901933

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2895889	0.87	PPARG (0.58)	PPARGPPARAPTGDR2AKR1B1
	SCHEMBL2901713	0.86	PPARG (0.75)	PPARGPPARAPTGDR2
	SCHEMBL2896754	0.85	PPARG (0.61)	PPARGPPARAPTGDR2
	SCHEMBL2898058	0.85	PPARG (0.74)	PPARG
	SCHEMBL2901679	0.85	PPARG (0.74)	PPARG
	SCHEMBL2898997	0.82	PTGDR2 (0.49)	PPARGPPARAPTGDR2AKR1B1NPBWR1
	SCHEMBL2901191	0.81	PPARG (0.72)	PPARGPPARA
	SCHEMBL2899000	0.80	PPARG (0.52)	PPARGPPARAPTGDR2
	SCHEMBL2896144	0.79	PPARG (0.82)	PPARGPTGDR2
	SCHEMBL2895348	0.78	PPARG (0.52)	PPARGPPARAPTGDR2AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.